Jianfeng Group announced that its subsidiary has obtained a registration certificate for tafluprost eye drops. This product is used to reduce elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension.
尖峰集团：子公司获得他氟前列素滴眼液药品注册证书
Jianfeng Group: The subsidiary obtained the registration certificate for tafluprost eye drops
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.